Susquehanna International Group’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.25M | Sell |
|
|||||
|
2025
Q1 | $2.27M | Buy |
|
|||||
|
2024
Q4 | $1.45M | Buy |
|
|||||
|
2024
Q3 | $1.46M | Sell |
|
|||||
|
2024
Q2 | $1.4M | Sell |
|
|||||
|
2024
Q1 | $2.15M | Buy |
|
|||||
|
2023
Q4 | $1.31M | Sell |
|
|||||
|
2023
Q3 | $1.94M | Sell |
|
|||||
|
2023
Q2 | $3.47M | Sell |
|
|||||
|
2023
Q1 | $7.85M | Buy |
|
|||||
|
2022
Q4 | $647K | Sell |
|
|||||
|
2022
Q3 | $2.97M | Buy |
|
|||||
|
2022
Q2 | $310K | Sell |
|
|||||
|
2022
Q1 | $2.76M | Sell |
|
|||||
|
2021
Q4 | $5.3M | Buy |
|
|||||
|
2021
Q3 | $2.63M | Buy |
|
|||||
|
2021
Q2 | $1.51M | Buy |
|
|||||
|
2021
Q1 | $864K | Sell |
|
|||||
|
2020
Q4 | $2.1M | Buy |
|
|||||
|
2020
Q3 | $587K | Buy |
|
|||||
|
2020
Q2 | $307K | Sell |
|
|||||
|
2020
Q1 | $703K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $917K | Buy |
|
|||||
|
2019
Q2 | $787K | Buy |
|
|||||
|
2018
Q3 | – | Hold |
|
|||||
|
2018
Q2 | – | Hold |
|